America Great Health
America Great Health is a U.S.-based pharmaceutical-preparations company that sells products through wholesale channels. Its disclosed operating model centers on product sales and bulk orders to U.S. wholesale accounts rather than subscription or service revenue.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaProduct sales within the company’s pharmaceutical-preparations business.
Bulk orders placed by U.S. wholesale accounts and commercial buyers.
Additional product transactions not separately identified in the disclosed reports.
Asiakkaat
The company sells primarily to U.S. wholesale accounts, with bulk orders representing an important source of sales. Wholesale buyers purchase products for resale or downstream distribution, making account retention and order timing important to revenue. The reports do not identify specific retailers, distributors, healthcare systems, or consumer brands.
Purchase pharmaceutical-preparation products in bulk for resale or distribution.
Source products for downstream supply to retailers and other commercial channels.
Potential downstream outlets receiving products through wholesale relationships.
Strategia
The company’s stated priorities are to raise additional capital, fund working capital, and reach profitable operations. Short-term funding has included loans and advances from shareholders, while future execution depends on securing sufficient capital and rebuilding wholesale order volume.
The company requires external funding to maintain operations and support working capital.
Major wholesale accounts materially affect revenue because the business relies on bulk product orders.
A sustainable profit base is needed to reduce dependence on external funding.
Maantiede
Q1/2026America Great Health’s disclosed operations and sales are concentrated in the United States. The March 2026 quarterly filing specifically attributes revenue changes to the temporary absence of major U.S. wholesale accounts, indicating that domestic customer concentration is important to operating performance.
Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.
Riskit
America Great Health faces substantial going-concern and financing risk because it reports recurring losses, limited cash, negative working capital, and dependence on shareholder funding. Its wholesale-centered model also creates customer-concentration and order-timing risk, while pharmaceutical product sales remain exposed to inventory obsolescence, regulatory requirements, competition, and product-quality issues.
The filing cites recurring losses, cash used in operations, negative working capital, and substantial doubt about continuing operations.
Working capital needs have been funded by short-term loans and advances from shareholders.
Kohdistuu: Future operations depend partly on new majority shareholders providing working capital.
The absence of major U.S. wholesale accounts caused a significant year-over-year sales contraction.
Pharmaceutical preparations require compliance with applicable manufacturing, labeling, safety, and distribution standards.
Slow-moving or obsolete pharmaceutical inventory may require write-downs to net realizable value.
Kirjanpito
Harkinnanvaraiset erätRevenue requires contract identification, performance-obligation analysis, transaction-price allocation, and satisfaction of obligations.
Vaikutus: Timing of wholesale delivery and fulfillment affects reported revenue and quarterly comparability.
Inventory is carried at the lower of FIFO cost or net realizable value, with provisions for slow-moving or obsolete items.
Vaikutus: Write-downs reduce inventory and gross profit; the company recorded a $9,000 provision.
Reported amounts depend on estimates including the fair value of common shares issued for services.
Vaikutus: Changes in valuation assumptions can affect expenses, equity, and reported losses.
Deferred tax assets are reduced when realization is not more likely than not.
Vaikutus: A valuation allowance of $7,784,371 at March 31, 2026 limits recognized tax benefits.
Debt settlement or extinguishment can create nonrecurring gains unrelated to core product sales.
Vaikutus: The reported nine-month 2026 net income included a $1,395,000 debt-extinguishment gain.
Financial instruments are assessed using a fair-value hierarchy, although cash and payables are short term.
Vaikutus: Changes in valuation inputs could affect reported assets, liabilities, or gains and losses.
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Hi-Great Group Holding Co
HIGR · Hotels & Motels
Hi-Great Group Holding Co is a development-stage U.S.
Agape ATP Corp
ATPC · Services-Health Services
Agape ATP Corp is a U.S.-listed health services company with a business model centered on wellness, preventive care, and related consumer health offerings.
American Healthcare REIT, Inc.
AHR · Real Estate Investment Trusts
Polomar Health Services, Inc.
PMHS · Pharmaceutical Preparations
DLH Holdings Corp.
DLHC · Services-Help Supply Services
AiXin Life International, Inc.
AIXN · Retail-Drug Stores and Proprietary Stores
Päivitetty: 8.9.2026